Do weight loss injections speed up your metabolism?

What the trial data tells us about weight loss and metabolic change

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed more than 2,500 adults over 72 weeks. Participants taking the highest dose of tirzepatide (the active ingredient in Mounjaro) lost an average of around 20–21% of their body weight. That scale of loss matters metabolically: carrying significantly less body mass reduces the work the heart, joints and metabolic system do at rest, and for many people improves insulin sensitivity, blood pressure and lipid profiles alongside it.

Semaglutide (Wegovy) produced average reductions of around 15% in the STEP 1 trial. Both medicines are GLP-1 receptor agonists — they mimic gut hormones that signal fullness to the brain and slow gastric emptying. Tirzepatide also activates the GIP receptor, a second pathway involved in energy regulation, making it the only dual-agonist weight-loss medicine currently licensed in the UK.

None of this means the injections act as a metabolic accelerant. They do not raise the number of calories your body burns at rest. What they do is make eating less feel physiologically manageable rather than a test of willpower — and that sustained reduction in energy intake, over months, is what drives the metabolic improvements seen in the data. The NHS patient information for tirzepatide describes the mechanism clearly if you want the detail.

The metabolic slowdown problem, and why these medicines partly address it

Here is the catch that frustrates most people who have tried dieting before. When you lose weight by cutting calories alone, your body adapts: resting metabolic rate falls, sometimes by more than the weight loss alone would predict. This adaptive thermogenesis is well-documented and is one reason weight regain is so common after conventional dieting.

GLP-1-based medicines do not switch off this adaptation entirely, but the evidence suggests the depth of adaptive metabolic suppression may be smaller when weight loss is achieved through appetite-hormone modulation rather than pure calorie restriction. Researchers are still working out exactly why. What is clearer is that people who combine these medicines with resistance exercise and sufficient dietary protein tend to preserve more lean muscle mass, and muscle is metabolically more active than fat tissue at rest.

So the honest answer to whether these injections speed up metabolism is: not directly, but by enabling meaningful fat loss while limiting muscle loss, they can protect metabolic rate better than many conventional approaches. That is meaningfully different from doing nothing, even if it is not the same as raising your metabolic rate above its original baseline.

For a broader look at how weight loss injections work in practice, our guide covers the mechanisms and the licensed options available in the UK.

Practical habits that support your metabolism during treatment

A question our prescribers hear regularly is what people can do day-to-day to get more from treatment. The evidence points consistently to three things: protein, resistance activity, and consistency with the medicine itself.

Protein keeps you fuller for longer and has a higher thermic effect than carbohydrate or fat, meaning the body uses more energy digesting it. On a reduced appetite, hitting a protein target takes conscious effort, spreading intake across meals rather than concentrating it at dinner makes a real difference. Resistance training, even twice a week, signals to the body to hold on to muscle during a calorie deficit. And taking the injection reliably on the same day each week maintains the steady hormone levels that underpin appetite control.

Storage matters here too. Both Mounjaro and Wegovy pens need refrigeration between 2–8°C; many people find keeping the current pen in the fridge door, next to things they reach for every morning, makes the weekly routine far easier to stick to. If you want to understand more about how a weight loss injection works and what to expect from each dose, our overview covers the practical detail. For exact storage windows, the Patient Information Leaflet that comes with your pen is the definitive guide.

If you are thinking about how long you need to take weight loss injections and what that commitment looks like over time, our page on treatment duration explains what the clinical evidence suggests about long-term use.

Who these medicines are licensed for, and the role of clinical assessment

Both Mounjaro and Wegovy are licensed for adults with a BMI of 30 or above, or 27 or above when at least one weight-related condition is present, things like high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. A BMI figure alone, though, does not determine whether treatment is right for you. A prescriber weighs up your full medical picture, including any medicines you already take, and questions about how many weight loss injections you will need are a regular part of that conversation.

NICE recommended tirzepatide in its appraisal TA1026 for eligible adults within the NHS rollout; private treatment through a regulated online pharmacy is the route for people who do not meet the current NHS criteria or prefer not to wait. Either way, the clinical assessment comes first, the medicine follows from it, not the other way around.

If you are curious about the BMI side of eligibility in more detail, this page walks through the numbers. And if you want to understand the 3 weight loss injections currently available and how they compare, our treatment overview sets out what is available.

Thinking about getting started? Speak to our prescribers through a free consultation, a real clinician reads your answers the same day and, if treatment is clinically suitable, your prescription is handled without delay.